Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus

Diabetologia

Volumn 54, Issue 1, 2011, Pages 73-77

  Van Dieren, S ^a   Nothlings U ^b,c   Van Der Schouw, Y T ^a   Spijkerman, A M W ^d   Rutten, G E H M ^a   Van Der A, D L ^d   Sluik, D ^b   Weikert, C ^b   Joost, H G ^b   Boeing, H ^b   Beulens, J W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Cardiovascular disease; Cholesterol; Coronary heart disease; Diabetes mellitus; Fasting lipids; Postprandial; Prediction; Triacylglycerol

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; EDUCATION; GEOGRAPHIC DISTRIBUTION; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; HUMANS; LIPIDS; POSTPRANDIAL PERIOD;

EID: 79953778422     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1945-z     Document Type: Article

References (10)

1. De Backer G (2009) New European guidelines for cardiovascular disease prevention in clinical practice. Clin Chem Lab Med 47:138-142
2. Mora S, Rifai N, Buring JE, Ridker PM (2008) Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 118:993-1001
3. Langsted A, Freiberg JJ, Nordestgaard BG (2008) Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 118:2047-2056
4. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A (2007) Nonfasting triacylglycerols and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298:299-308 (Pubitemid 47080484)
5. Chen YDI, Swami S, Skowronski R, Coulston A, Reaven GM (1993) Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 76:172-177 (Pubitemid 23027575)
6. Stevens RJ, Kothari V, Adler AI, Stratton IM (2001) The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 101:671-679 (Pubitemid 33135349)
7. Boeing H, Wahrendorf J, Becker N (1999) EPIC-Germany - a source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition. Ann Nutr Metab 43:195-204
8. Beulens JWJ, Monninkhof EM, Verschuren WMM, van der Schouw YT, Smit J, Ocke MC et al. (2010) Cohort profile: the EPIC-NL Study. Int J Epidemiol. doi:10.1093/ije/dyp217
9. Sluijs I, van der AD, Beulens JW et al (2010) Ascertainment and verification of diabetes in the EPIC-NL Study. Neth J Med 68:333-339
10. Eberly LE, Stamler J, Neaton JD (2003) Relation of triacylglycerol levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Arch Intern Med 163:1077-1083 (Pubitemid 36548936)